Clinical Trials
3 trialsNCT00391521 2014-01-30
AS703569 Phase I in Patients With Solid Tumours
EMD Serono
Phase 1 Completed
NCT01097512 2014-01-30
AS703569 and Gemcitabine Combination in Advanced Malignancies
Merck KGaA, Darmstadt, Germany
Phase 1 Completed
NCT01080664 2013-10-22
A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies
EMD Serono
Phase 1 Terminated